Casdin Capital LLC insider trades

Open-market stock purchases and sales by Casdin Capital LLC, Director, 10% Owner at GeneDx Holdings Corp, from SEC Form 4 filings since Jul 23, 2018.

Track record: 63% of 8 scored buys are up 5% or more since purchase, averaging +44%.

Recent trades

DateStockTradeValue
Jun 5, 2026WGS GeneDx Holdings CorpBought$2.6M
Jun 4, 2026WGS GeneDx Holdings CorpBought$8.5M
May 20, 2026WGS GeneDx Holdings CorpBought$6.1M
May 19, 2026WGS GeneDx Holdings CorpBought$7.9M
May 18, 2026WGS GeneDx Holdings CorpBought$7.4M
May 11, 2026WGS GeneDx Holdings CorpBought—
May 8, 2026WGS GeneDx Holdings CorpBought—
May 7, 2026WGS GeneDx Holdings CorpBought—

Companies traded

  • WGS GeneDx Holdings Corp: 17 buys, 1 sale, last Jun 5, 2026
  • TSVT 2seventy bio, Inc: 4 buys, 1 sale, last May 13, 2025
  • GBIO Generation Bio Co: 1 buy, last Jun 16, 2020
  • FULC Fulcrum Therapeutics, Inc: 3 buys, last Jul 22, 2019
  • CNST Constellation Pharmaceuticals Inc: 1 buy, last Jul 23, 2018

Get free alerts when Casdin Capital LLC files a new trade →